8 results match your criteria: "Hospital Rainha Santa Isabel[Affiliation]"
Elbow septic arthritis in an infant: an unusual presentation of invasive pneumococcal disease.
BMJ Case Rep
December 2023
Pediatrics, Centro Hospitalar do Médio Tejo, Hospital Rainha Santa Isabel, Torres Novas, Portugal.
Acute septic arthritis is a rare, potentially severe infection that requires immediate treatment to avoid long-term morbidity. Most common aetiological agents are commonly used for empirical treatment, but the choice of antibiotics may be influenced by other factors, such as the patient's age and the epidemiological context.We report an infant with elbow arthritis, whose treatment was changed after serotype 9N was isolated in the blood and synovial fluid.
View Article and Find Full Text PDFHumoral response to BNT162b2 mRNA COVID-19 vaccine in peritoneal and hemodialysis patients: A comparative study.
Ther Apher Dial
August 2022
Department of Nephrology, Centro Hospitalar do Médio Tejo, Hospital Rainha Santa Isabel, Torres Novas, Portugal.
Introduction: Maintenance dialysis patients (MDP) are at higher risk of exposure with increased mortality from COVID-19 with generalized immunization becoming the cornerstone in prevention. This study aims to compare humoral response between hemodialysis (HD) and peritoneal dialysis (PD) patients.
Materials And Methods: Observational prospective study following HD and PD programs from a Portuguese Center receiving BNT162b2 vaccine.
The time to offer treatments for COVID-19.
Expert Opin Investig Drugs
May 2021
Department of Internal Medicine, Rocky Mountain Regional Veterans Affairs Medical Center in Aurora, CO and University of Colorado Anschutz Medical Campus in Aurora, CO Supported by the Emily Foundation, Boston, USA.
Article Synopsis
- The COVID-19 pandemic has multiple phases, with current treatment strategies largely focusing on late-stage disease in hospitals, while the viral phase in outpatients remains a key issue.* -
- A review of 111 publications identified only 21 focusing on outpatient care, highlighting an imbalance in research and available treatments for patients not requiring hospitalization.* -
- The authors advocate for public health authorities to approve low-risk treatments for outpatients alongside vaccination efforts, especially in light of emerging SARS-CoV-2 variants and limited monoclonal antibody supply.*
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.
AIDS Rev
February 2021
Eastern Virginia Medical School|, Department of Internal Medicine, Chief, Pulmonary and Critical Care Medicine, Norfolk, VA, USA.
Article Synopsis
- COVID-19, caused by the SARS-CoV-2 virus, is a significant health issue that first emerged in December 2019 in Wuhan, China, leading to various treatments being explored over time.
- The text discusses the importance of understanding the different stages and phases of COVID-19 to effectively time the use of therapeutics and improve patient outcomes.
- The authors propose a framework that outlines key periods and phases of the disease, which can help guide research and treatment decisions for COVID-19 therapies.
Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.
J Med Virol
February 2021
Unidade de Investigação Cardiovascular (UniC), Faculdade de Medicina, Universidade do Porto, Hospital CUF, Porto, Portugal.
Hydroxychloroquine sulfate (HCQ) is being scrutinized for repositioning in the treatment and prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This antimalarial drug is also chronically used to treat patients with autoimmune diseases. By analyzing the Portuguese anonymized data on private and public based medical prescriptions we have identified all cases chronically receiving HCQ for the management of diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases.
View Article and Find Full Text PDFLate Cytomegalovirus Infection in Kidney Transplant Recipients after a Six-Month Prevention Protocol.
Int J Organ Transplant Med
February 2010
Renal Transplantation Department, Hospital de Santa Cruz, Lisboa, Portugal.
Background: Despite a reduction in the incidence of cytomegalovirus (CMV) infections after kidney transplantation, less is known about late CMV infection in kidney transplant recipients.
Objective: To assess incidence of CMV infection in a cohort of patients under a high surveillance CMV prevention protocol and identify factors associated with late CMV infection.
Methods: Analysis of a consecutive cohort of 181 kidney allograft recipients between January 2012 and Aug 2015.